The US Food and Drug Administration (FDA) has approved certo
Vineesh Allenki
The US Food and Drug Administration (FDA) has approved certolizumab pegol injection (Cimzia) for the treatment of adults with non-radiographic axial spondyloarthritis (nr-axSpA), with objective signs of inflammation. This is the first FDA-approved treatment for the inflammatory arthritis condition.(Dated:28-03-2019)
Like
Comment
Share